F-18 Rhodamine 6G

N/A

Report date: 2025/11/27 17:57:29

NME

Base Information

Drug NameF-18 Rhodamine 6G

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent

Mechanisms of ActionRadionuclide imaging enhancers

TargetsNot applicable

Therapy Area/IndicationsHyperaldosteronismCoronary Artery Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesWashington University School Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Cambridge

Inactive CompaniesWashington University School Of Medicine

Active IndicationsHyperaldosteronism

Inactive IndicationsCoronary Artery Disease

Other Information

ATC CodeN/A